[go: up one dir, main page]

WO2013091974A3 - Verwendung von einer kombination von 2-methyl-1,4,5,6-tetrahydro-4-pyrimidincarbonsäure oder deren derivat und einem blaualgenextrakt zur steigerung der hautbarrierefunktion - Google Patents

Verwendung von einer kombination von 2-methyl-1,4,5,6-tetrahydro-4-pyrimidincarbonsäure oder deren derivat und einem blaualgenextrakt zur steigerung der hautbarrierefunktion Download PDF

Info

Publication number
WO2013091974A3
WO2013091974A3 PCT/EP2012/071820 EP2012071820W WO2013091974A3 WO 2013091974 A3 WO2013091974 A3 WO 2013091974A3 EP 2012071820 W EP2012071820 W EP 2012071820W WO 2013091974 A3 WO2013091974 A3 WO 2013091974A3
Authority
WO
WIPO (PCT)
Prior art keywords
tetrahydro
methylene
blue
combination
green algae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2012/071820
Other languages
English (en)
French (fr)
Other versions
WO2013091974A2 (de
Inventor
Ira Hartmann
Soraya Heinen
Marianne DR. WALDMANN-LAUE
Claudia Jassoy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of WO2013091974A2 publication Critical patent/WO2013091974A2/de
Publication of WO2013091974A3 publication Critical patent/WO2013091974A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)

Abstract

Eine Kombination aus mindestens einer Verbindung aus 2-Methyl-1,4,5,6-tetrahydro-4-pyrimidincarbonsäure oder deren Derivate, und mindestens einem Blaualgenextrakt, und gegebenenfalls mindestens einem fucosehaltigen Polysaccharid (insbesondere in der Ausführung eines der kosmetischen Mittel der Ansprüche 1 bis 6) stimuliert die epidermalen Synthese von Filaggrin und/oder Transglutaminiase und/oder Involucrin. Die Hautbarriere wird gestärkt.
PCT/EP2012/071820 2011-12-22 2012-11-05 Verwendung von einer kombination von 2-methyl-1,4,5,6-tetrahydro-4-pyrimidincarbonsäure oder deren derivat und einem blaualgenextrakt zur steigerung der hautbarrierefunktion Ceased WO2013091974A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102011089582.5 2011-12-22
DE102011089582A DE102011089582A1 (de) 2011-12-22 2011-12-22 Verwendung von einer Kombination von 2-Methyl-1,4,5,6-tetrahydro-4-pyrimidincarbonsäure oder deren Derivat und einem Blaualgenextrakt zur Steigerung der Hautbarrierefunktion

Publications (2)

Publication Number Publication Date
WO2013091974A2 WO2013091974A2 (de) 2013-06-27
WO2013091974A3 true WO2013091974A3 (de) 2013-08-15

Family

ID=47137721

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/071820 Ceased WO2013091974A2 (de) 2011-12-22 2012-11-05 Verwendung von einer kombination von 2-methyl-1,4,5,6-tetrahydro-4-pyrimidincarbonsäure oder deren derivat und einem blaualgenextrakt zur steigerung der hautbarrierefunktion

Country Status (2)

Country Link
DE (1) DE102011089582A1 (de)
WO (1) WO2013091974A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3015283B1 (fr) * 2013-12-23 2016-12-09 Oreal Composition comprenant une forte teneur d'hydrolat
CN106265477A (zh) * 2016-09-28 2017-01-04 珠海姗拉娜化妆品有限公司 一种用于美白护肤品的组合物
CN107184410A (zh) * 2017-04-28 2017-09-22 广州瑞誉化工科技有限公司 一种具有激素依赖性皮炎修复功能的润肤霜

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4342560A1 (de) * 1993-12-14 1995-06-22 Marbert Gmbh Ectoin und Ectoinderivate als Feuchtigkeitsspender in Kosmetikprodukten
DE10059107A1 (de) * 1999-12-23 2001-06-28 Henkel Kgaa Extrakt aus der Blaualge Spirulina und seine Verwendung in kosmetischen und dermatologischen Mitteln zur Haut- und Körperpflege
WO2001072263A2 (de) * 2000-03-24 2001-10-04 Merck Patent Gmbh Verwendung von ectoin oder ectoin-derivaten zum schutz der stressprotein in der haut
DE102006062566A1 (de) * 2006-12-29 2008-07-03 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen gegen unreine Haut und/oder Akne
DE102008061045A1 (de) * 2008-12-11 2009-10-08 Henkel Ag & Co. Kgaa Verwendung von epsilon-Viniferin

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4342560A1 (de) * 1993-12-14 1995-06-22 Marbert Gmbh Ectoin und Ectoinderivate als Feuchtigkeitsspender in Kosmetikprodukten
DE10059107A1 (de) * 1999-12-23 2001-06-28 Henkel Kgaa Extrakt aus der Blaualge Spirulina und seine Verwendung in kosmetischen und dermatologischen Mitteln zur Haut- und Körperpflege
WO2001072263A2 (de) * 2000-03-24 2001-10-04 Merck Patent Gmbh Verwendung von ectoin oder ectoin-derivaten zum schutz der stressprotein in der haut
DE102006062566A1 (de) * 2006-12-29 2008-07-03 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen gegen unreine Haut und/oder Akne
DE102008061045A1 (de) * 2008-12-11 2009-10-08 Henkel Ag & Co. Kgaa Verwendung von epsilon-Viniferin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Jurlique Facial Serum", 1 June 2010 (2010-06-01), pages 1 - 5, XP055068346, Retrieved from the Internet <URL:http://www.gnpd.com/sinatra/gnpd/search_results&search_id=kPelZqYux6/&p_page_number=3&item_id=1355482> [retrieved on 20130625] *

Also Published As

Publication number Publication date
DE102011089582A1 (de) 2013-06-27
WO2013091974A2 (de) 2013-06-27

Similar Documents

Publication Publication Date Title
EP3488815C0 (de) Kosmetische hautverjüngung
PL2640352T3 (pl) Hydrolizat kolagenu do zastosowania do poprawy zdrowia ludzkiej skóry, włosów i/lub paznokci
EP3052076A4 (de) Wässrige lotionshautpflegezusammensetzungen und verfahren
WO2011122869A3 (ko) 쿠메스트롤 또는 쿠메스트롤을 포함하는 콩 추출물을 포함하는 피부 미용용 조성물
MX347848B (es) Uso cosmético de las sulfoniloxibencilaminas n-sustituidas y compuestos relacionados.
WO2013006335A3 (en) Methods and compositions useful for treating fitzpatrick type iv, v or vi skin
WO2012076109A3 (de) 2-pyrone
WO2013028267A3 (en) Cosmetic use of substituted amino heterocyclic carbamoyl analogs and related compounds
WO2014043230A3 (en) Formulations comprising idebenone, n-acetyl-s-farnesyl-l-cysteine and ergothioneine and uses thereof
WO2009112653A3 (fr) Composition cosmétique et/ou dermatologique
WO2014037903A3 (en) Cosmetic compositions comprising eicosapentaeninic free acid and gamma-linopenic free acid and methods of making and using same
WO2012024399A3 (en) Compositions comprising paulownin and/or paulownia extracts and uses thereof
WO2013091974A3 (de) Verwendung von einer kombination von 2-methyl-1,4,5,6-tetrahydro-4-pyrimidincarbonsäure oder deren derivat und einem blaualgenextrakt zur steigerung der hautbarrierefunktion
WO2013117859A3 (fr) Utilisation d&#39;un principe actif issu d&#39;eucheuma cottonii riche en galactanes lineaires pour lutter contre la senescence cellulaire cutanee
WO2014090615A3 (de) Quick breaking emulsion
WO2011107866A3 (en) Silyl-derivatives of polysaccharides
WO2014140485A3 (fr) Composition cosmétique ou dermatologique et son utilisation
WO2014023649A3 (en) Dermal cosmetic compositions having osmoprotecting activity
WO2012065671A3 (de) Verwendung von ascorbinsäurederivaten zur färbung von keratinhaltigen fasern
WO2013064388A3 (de) Kosmetische formulierung enthaltend n-acyl - phytosphingosin
WO2014164053A3 (en) Pigmented skin-care compositions
WO2014164052A3 (en) Pigmented skin-care compositions
ZA201300413B (en) Xanthenedione derivatives for the treatment of pigmentation and skin ageing disorders
FR2999080B1 (fr) Utilisation cosmetique de l&#39;association d&#39;un extrait de de germe de caroube et de cafeine en tant qu&#39;agent actif amincissant
WO2010010248A3 (fr) Composition cosmetique comprenant un extrait aqueux de chrysophyllum cainito

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12781100

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12781100

Country of ref document: EP

Kind code of ref document: A2